Generally speaking, CD20+ malignant T lymphoma cells are positive for CD3 and monoclonal TCR gene rearrangements and negative for CD10, CD19, or CD79a and clonal IgH gene rearrangements. The gene discussed is CD19; the disease is lymphoma.